Login
$SPRY
$3.92 -$0.11 (2.73%) Close

Company Executives

$SPRY Management Team

Dr. Pratik Shah

Chairman of the Board

Age 55
Compensation $542.9K USD
Sex Male

Mr. Richard Lowenthal

President

Chief Executive Officer

Director

Age 59
Compensation $7.175M USD
Sex Male

Ms. Kathleen Scott

Chief Financial Officer

Age 56
Compensation -
Sex Female

Mr. Brian Dorsey

Chief Operating Officer

Age 56
Compensation $2.235M USD
Sex Male

Mr. Justin Chakma

Chief Business Officer

Age 36
Compensation -
Sex Male

Mr. Eric Karas

Chief Commercial Officer

Age 53
Compensation $222.6K USD
Sex Male

Dr. Sarina Tanimoto

Chief Medical Officer

Age 56
Compensation $4.247M USD
Sex Female

Mr. Alexander Fitzpatrick

Secretary and Chief Legal Officer

Age 58
Compensation $5.318M USD
Sex Male
Directors
10
serving now
Independent
8 of 10
stated in the proxy
Average tenure
6.2 years
from year joined
CEO also chairs the board
No
Pratik Shah
Director Age On board Independent Committees Other public boards Pay Source
Saqib Islam
56 2022
4 years
Independent None stated None stated Not stated
Phillip Schneider
70 2019
7 years
Independent None stated None stated Not stated
Laura Shawver
68 2022
4 years
Independent
Compensation Committee
None stated Not stated
Rajeev Dadoo
56 2021
5 years
Independent
Audit Committee
None stated Not stated
Michael Kelly
61 2019
7 years
Independent
Audit Committee
None stated Not stated
Pratik Shah
56 2016
10 years
Not independent None stated None stated Not stated
Richard Lowenthal
60 2015
11 years
Not independent None stated None stated Paid as CEO
Peter Kolchinsky
49 2021
5 years
Independent None stated WAVE Life Sciences, Ltd. Not stated
Brenton L. Saunders
56 2021
5 years
Independent None stated The Beauty Health Company Not stated
Peter A. Thompson
66 2022
4 years
Independent None stated Corvus Pharmaceuticals, Inc., Edgewise Therapeutics, Inc., Sionna Therapeutics Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support